Anna Fehr is the co-owner and CEO of One of a Kind (1-OAK) Clinical Research Center, a multi-site research organization. With over a decade of experience in clinical research, she leads daily operations across trial startup, regulatory compliance, GCP adherence, ALCOA practices, patient care, and provider engagement. Anna holds a bachelor’s degree in nursing with a specialization in critical care oncology. Under her leadership, 1-OAK Clinical Research conducts studies across diverse therapeutic areas including immunology, asthma, rare disease, gastroenterology, neurology, interventional radiology, rheumatology, primary care, sleep medicine, Cardiology and dermatology.
